Abstract
The gravid patient will typically experience few difficulties during the course of her pregnancy. A small but significant number of pregnant patients will become ill enough to require the intensive care unit for both obstetrical and non-obstetrical problems. Therefore, the obstetrical physician must have an understanding of how to monitor and manage the critically ill pregnant patient and how to approach emergencies unique to pregnancy. In a report of ICU utilization during hospital admission for delivery in the United States in one state, 822,591 admissions from 1984 to 1997 were analyzed. There were 1,023 admissions to the intensive care unit, with mortality in the ICU of 3.3% (1). Predictors for ICU admission in this retrospective analysis included: age greater than 35 (Odds Ratio [OR] 1.4), African-American ethnicity (OR 1.8), race other than black or white (OR 5.9), treatment in minor teaching hospital (OR 2.0), and transfer to a higher-level hospital for care (OR 2.51) (1). The most common indication for ICU admission involved obstetrical related complications. These included complications of cesarean section, preeclampsia or eclampsia, and peripartum hemorrhage (1–4). The most common risk factors associated with ICU mortality included pulmonary complications, shock, cerebrovascular events, and drug dependence(1). In another study looking at 74 obstetric patients admitted to an ICU over 7 years, the most common reason for admission was respiratory insufficiency (5). Outside of the United States, a much smaller study of ICU admissions in the United Arab Emirates demonstrated similar mortality rates (6). In another series, a majority of obstetric patients admitted (71%) to the ICU required ventilatory support (7).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Panchal S, Arria AM, Harris AP. Intensive care utilization during hospital admission for delivery: prevalence, risk factors, and outcomes in a statewide population. Anesthesiology 2000;92(6):1537–44.
Martin SR, Foley MR. Intensive care in obstetrics: an evidence-based review. Am J Obstet Gynecol 2006;195(3):673–89.
Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case-control study. BMJ 2001;322(7294):1089–93; discussion 93–4.
Karnad DR, Guntupalli KK. Critical illness and pregnancy: review of a global problem. Crit Care Clin 2004;20(4):555–76, vii.
Afessa B, Green B, Delke I, Koch K. Systemic inflammatory response syndrome, organ failure, and outcome in critically ill obstetric patients treated in an ICU. Chest 2001;120(4):1271–7.
Mirghani HM, Hamed M, Ezimokhai M, Weerasinghe DS. Pregnancy-related admissions to the intensive care unit. Int J Obstet Anesth 2004;13(2):82–5.
Zeeman GG, Wendel GD, Jr., Cunningham FG. A blueprint for obstetric critical care. Am J Obstet Gynecol 2003;188(2):532–6.
Karnad DR, Lapsia V, Krishnana A, et al. Prognostic factors in obstetric patients admitted to an Indian intensive care unit. Crit Care Med 2004;32:1294–9.
Kilpatrick SJ, Matthay MA. Obstetric patients requiring critical care. A five-year review. Chest 1992;101(5):1407–12.
Scarpinato L. Critically ill obstetric patients: outcome and predictability utilizing the SAPS II score in a 314 bed community hospital. Chest 1995;108:184S.
Koch K, HD. R, Sanchez-Ramos L. Critically ill obstetrical patients: outcome and predictability. Crit Care Med 1988;16:A409.
el-Solh AA, Grant BJ. A comparison of severity of illness scoring systems for critically ill obstetric patients. Chest 1996;110(5):1299–304.
Belfort MA, Mares A, Saade G, Wen T, Rokey R. Two-dimensional echocardiography and Doppler ultrasound in managing obstetric patients. Obstet Gynecol 1997;90(3):326–30.
Belfort MA, Rokey R, Saade GR, Moise KJ, Jr. Rapid echocardiographic assessment of left and right heart hemodynamics in critically ill obstetric patients. Am J Obstet Gynecol 1994;171(4):884–92.
Lee W, Gonik B, Cotton DB. Urinary diagnostic indices in preeclampsia-associated oliguria: correlation with invasive hemodynamic monitoring. Am J Obstet Gynecol 1987;156(1):100–3.
Lorente L, Henry C, Martin MM, Jimenez A, Mora ML. Central venous catheter-related infection in a prospective and observational study of 2,595 catheters. Crit Care 2005;9(6):R631–5.
Connors AJ, Speroff T, Dawson N, Thomas C, Harrell FJ, Wagner D. The effectiveness of right heart catheterization in the initial care of critically ill patients: SUPPORT investigators. JAMA 1996;276:889–97.
Sandham J, Hull R, Brant R, et al. A randomized, controlled trial of the use of the pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003;348:5–14.
Naeye RL. Abruptio placentae and placenta previa: frequency, perinatal mortality, and cigarette smoking. Obstet Gynecol 1980;55(6):701–4.
Finley BE. Acute coagulopathy in pregnancy. Med Clin North Am 1989;73(3):723–43.
Salihu HM, Bekan B, Aliyu MH, Rouse DJ, Kirby RS, Alexander GR. Perinatal mortality associated with abruptio placenta in singletons and multiples. Am J Obstet Gynecol 2005;193(1):198–203.
Hayashi RH. Hemorrhagic shock in obstetrics. Clin Perinatol 1986;13(4):755–63.
Suner S, Jagminas L, Peipert JF, Linakis J. Fatal spontaneous rupture of a gravid uterus: case report and literature review of uterine rupture. J Emerg Med 1996;14(2):181–5.
Toppenberg KS, Block WA, Jr. Uterine rupture: what family physicians need to know. Am Fam Physician 2002;66(5):823–8.
Guise JM, McDonagh MS, Osterweil P, Nygren P, Chan BK, Helfand M. Systematic review of the incidence and consequences of uterine rupture in women with previous caesarean section. BMJ 2004;329(7456):19–25.
Smith GC, Pell JP, Pasupathy D, Dobbie R. Factors predisposing to perinatal death related to uterine rupture during attempted vaginal birth after caesarean section: retrospective cohort study. BMJ 2004;329(7462):375.
Leung AS, Leung EK, Paul RH. Uterine rupture after previous cesarean delivery: maternal and fetal consequences. Am J Obstet Gynecol 1993;169(4):945–50.
Flamm BL, Goings JR, Liu Y, Wolde-Tsadik G. Elective repeat cesarean delivery versus trial of labor: a prospective multicenter study. Obstet Gynecol 1994;83(6):927–32.
Rouse DJ, Leindecker S, Landon M, et al. The MFMU Cesarean Registry: uterine atony after primary cesarean delivery. Am J Obstet Gynecol 2005;193(3 Pt 2):1056–60.
Lapinsky SE, Kruczynski K, Slutsky AS. Critical care in the pregnant patient. Am J Respir Crit Care Med 1995;152(2):427–55.
Levy M, Fink M, Marshall J, et al. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250–6.
Gibbs RS. Severe infections in pregnancy. Med Clin North Am 1989;73(3):713–21.
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345(19):1368–77.
Hollmen AI, Jouppila R, Albright GA, Jouppila P, Vierola H, Koivula A. Intervillous blood flow during caesarean section with prophylactic ephedrine and epidural anaesthesia. Acta Anaesthesiol Scand 1984;28(4):396–400.
Hollmen AI, Jouppila R, Jouppila P. Regional anaesthesia and uterine blood flow. Ann Chir Gynaecol 1984;73(3):149–52.
Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus: DIGAMI (diabetes mellitus, insulin glucose infusion in acute myocardial infarction) study group. BMJ 1997;314:1512–5.
van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359–67.
Hotchkiss R, Karl I. The pathophysiology and treatment of sepsis. N Engl J Med 2003;344:759–62.
Matthay MA. Severe sepsis: a new treatment with both anticoagulant and antiinflammatory properties. N Engl J Med 2001;344:759–62.
Bernard G, Vincent J, Laterre P, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001;344:699–709.
von Dadelszen P, Magee LA, Lee SK, et al. Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med 2002;30(8):1883–92.
Medve L, Csitari IK, Molnar Z, Laszlo A. Recombinant human activated protein C treatment of septic shock syndrome in a patient at 18th week of gestation: a case report. Am J Obstet Gynecol 2005;193(3 Pt 1):864–5.
Mikaszewska-Sokolewicz M, Mayzner-Zawadzka E. Use of recombinant human activated protein C in treatment of severe sepsis in a pregnant patient with fully symptomatic ovarian hyperstimulation syndrome. Med Sci Monit 2005;11(6):CS27–32.
Cronin L, Cook DJ, Carlet J, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995;23(8):1430–9.
Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995;23(7):1294–303.
Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003;348(2):138–50.
Strek M, O'Connor M, Hall J. Critical Illness in Pregnancy. 2nd ed. New York: McGraw-Hill; 1998.
Ramsey PS, Ramin KD, Ramin SM. Cardiac disease in pregnancy. Am J Perinatol 2001;18(5):245–66.
Gowda R, Khan I, Mehta N, Vasavada B, Sacchi T. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol 2003;88:129–33.
Siu S, Sermer M, Colman J, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515–21.
Fishburne JI, Meis PJ, Urban RB, et al. Vascular and uterine responses to dobutamine and dopamine in the gravid ewe. Am J Obstet Gynecol 1980;137(8):944–52.
Homans DC. Peripartum cardiomyopathy. N Engl J Med 1985;312(22):1432–7.
Abboud J, Murad Y, Chen-Scarabelli C, Saravolatz L, Scarabelli TM. Peripartum cardiomyopathy: A comprehensive review. Int J Cardiol 2007.
Sullivan JM, Ramanathan KB. Management of medical problems in pregnancy – severe cardiac disease. N Engl J Med 1985;313(5):304–9.
Lamparter S, Pankuweit S, Maisch B. Clinical and immunologic characteristics in peripartum cardiomyopathy. Int J Cardiol 2006.
Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet 2006;368(9536):687–93.
Mabie WC, Freire CM. Sudden chest pain and cardiac emergencies in the obstetric patient. Obstet Gynecol Clin North Am 1995;22(1):19–37.
Lindheimer MD, Katz AI. Preeclampsia: pathophysiology, diagnosis, and management. Annu Rev Med 1989;40:233–50.
Sibai BM, Frangieh AY. Management of severe preeclampsia. Curr Opin Obstet Gynecol 1996;8(2):110–3.
Mushambi MC, Halligan AW, Williamson K. Recent developments in the pathophysiology and management of pre-eclampsia. Br J Anaesth 1996;76(1):133–48.
Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996;335(4):257–65.
Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111(5):649–58.
Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350(7):672–83.
Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2003(2):CD000025.
Duley L, Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev 2003(4):CD000127.
Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev 2003(4):CD000128.
Sibai BM, Kustermann L, Velasco J. Current understanding of severe preeclampsia, pregnancy-associated hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, hemolysis, elevated liver enzymes, and low platelet syndrome, and postpartum acute renal failure: different clinical syndromes or just different names? Curr Opin Nephrol Hypertens 1994;3(4):436–45.
Chang J, Elam-Evans L, Berg C, et al. Pregnancy-related mortality surveillance: United States 1991–1999. MMWR Surveill Summ 2003;52:1–8.
Hirsch DR, Mikkola KM, Marks PW, et al. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden. Am Heart J 1996;131(6):1145–8.
Barbour LA, Smith JM, Marlar RA. Heparin levels to guide thromboembolism prophylaxis during pregnancy. Am J Obstet Gynecol 1995;173(6):1869–73.
Rodger MA. Avruch LI. Howley HE. Olivier A. Walker MC. Pelvic magnetic resonance venography reveals high rate of pelvic vein thrombosis after cesarean section. Am J Obstet Gynecol 2006;194(2):436–7.
Shiach CR. Monitoring of low molecular weight heparin in pregnancy. Hematology 2003;8(1):47–52.
Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119(1 Suppl):122S–31S.
Hirsh J, Dalen J, Guyatt G. The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. American College of Chest Physicians. Chest 2001;119(1 Suppl):1S–2S.
Clark SL, Blatter DD, Jackson GM. Placement of a temporary vena cava filter during labor. Am J Obstet Gynecol 2005;193(5):1746–7.
Dulitzki M, Pauzner R, Langevitz P, Pras M, Many A, Schiff E. Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies. Obstet Gynecol 1996;87(3):380–3.
Masson RG. Amniotic fluid embolism. Clin Chest Med 1992;13(4):657–65.
Clark SL. Amniotic fluid embolism. Clin Perinatol 1986;13(4):801–11.
Giampaolo C, Schneider V, Kowalski BH, Bellaver LA. The cytologic diagnosis of amniotic fluid embolism: a critical reappraisal. Diagn Cytopathol 1987;3(2):126–8.
Rees GA, Willis BA. Resuscitation in late pregnancy. Anaesthesia 1988;43(5):347–9.
Joglar JA, Page RL. Antiarrhythmic drugs in pregnancy. Curr Opin Cardiol 2001;16(1):40–5.
Ferrero S, Colombo BM, Ragni N. Maternal arrhythmias during pregnancy. Arch Gynecol Obstet 2004;269(4):244–53.
DePace NL, Betesh JS, Kotler MN. ‘Postmortem’ cesarean section with recovery of both mother and offspring. JAMA 1982;248(8):971–3.
Mallampalli A, Guy E. Cardiac arrest in pregnancy and somatic support after brain death. Crit Care Med 2005;33(10 Suppl):S325–31.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hogarth, D.K., Hall, J. (2009). Critical Illness in Pregnancy. In: Rosene-Montella, K., Bourjeily, G. (eds) Pulmonary Problems in Pregnancy. Respiratory Medicine. Humana Press. https://doi.org/10.1007/978-1-59745-445-2_21
Download citation
DOI: https://doi.org/10.1007/978-1-59745-445-2_21
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-934115-12-1
Online ISBN: 978-1-59745-445-2
eBook Packages: MedicineMedicine (R0)